Senate Bill 18-023: The Free Speech in Medicine Act0

• HEALTH CARE, Issue Backgrounder
• February 12, 2018

IB-A-2018 (February 2018) Author: Linda Gorman DOWNLOAD REPORT IN PDF Executive Summary: The question is whether prohibiting the dissemination of truthful medical information about off-label use of prescription drugs does more good than harm.